Login / Signup

Intravenous iron supplementation does not increase infectious disease risk in hemodialysis patients: a nationwide cohort-based case-crossover study.

Chieh-Li YenYu-Sheng LinYueh-An LuHsin-Fu LeeCheng-Chia LeeYing-Chang TungGeorge KuoLung-Sheng WuYa-Chung TianPao-Hsien Chu
Published in: BMC nephrology (2019)
We found that intravenous iron supplementation did not increase short-term infection risk among HD patients.
Keyphrases
  • infectious diseases
  • end stage renal disease
  • high dose
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • patient reported outcomes
  • iron deficiency